Arbaclofen Extended-Release for Spasticity in Multiple Sclerosis: Responder Analysis of a Phase 3 Randomized, Placebo-Controlled Clinical Study OS440-3004
Background: Arbaclofen is the active R-enantiomer of racemic baclofen. Arbaclofen extended-release (ER) tablets have demonstrated efficacy...
Identifying and Characterizing Fatigue in Patients Diagnosed with Multiple Sclerosis on Disease-Modifying Therapies Using Real World Evidence
Background: Fatigue is a common symptom in patients with Multiple Sclerosis (MS). Payor databases represent an important source of real...
Occupational Therapy Delivered Emotional Regulation Interventions: A Case-Series of Female Patients with Multiple Sclerosis
Background: Emotional health disorders are common in the Multiple Sclerosis (MS) population and can cause significant deficits in quality...
Validation and Minimal Detectable Change of the Walking While Talking Test As a Measure of Dual-Task Performance in Ambulatory Individuals with Multiple Sclerosis
Background: Multiple Sclerosis (MS) is a progressive neurodegenerative disease associated with demyelination of the central nervous system...
Attitude and Perception of Multiple Sclerosis Patients Toward Exercise
Background: Contrary to the common belief that physical training for Multiple Sclerosis (MS) patients might exacerbate fatigue and provoke...
A Scoping Review of Task-Oriented Exercise Effects on Motor Function in People with Multiple Sclerosis
Background: Exercise improves cardiorespiratory and musculoskeletal fitness for people with multiple sclerosis (MS). Recent work suggests...